Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients



Status:Completed
Conditions:Blood Cancer, Hematology, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:18 - 95
Updated:2/8/2015
Start Date:October 2013
End Date:June 2015
Contact:Senu Apewokin, MD
Email:skapewokin@uams.edu
Phone:5015266990

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients and Its Performance as an Adjunct in the Diagnosis and Prognostication of Infectious Processes

An observational study in evaluating the clinical impact of procalcitonin on the care of
Stem cell transplant recipient and its performance as an adjunct in the diagnosis and
prognostication of Infectious processes

The overall goal of this project will be to provide new insights into the use of biomarkers
in surveillance for infectious processes in Stem Cell Transplant recipients by evaluating
the added impact of procalcitonin testing on detection of infectious processes

Inclusion Criteria:

- Patients age 18-95 years with Multiple Myeloma (MM) undergoing stem cell
transplantation

Exclusion Criteria:

- None
We found this trial at
1
site
University of Arkansas for Medical Sciences
529 West Markham Street
Little Rock, Arkansas 72205
(501) 686-7000
University of Arkansas for Medical Sciences The University of Arkansas for Medical Sciences (UAMS) in...
?
mi
from
Little Rock, AR
Click here to add this to my saved trials